Kusajili – Clinical trials directory

Result of your search per sponsor: Andreas Hochhaus, Prof. MD

Woman and Man Max 99 years
Andreas Hochhaus, Prof. MD Update Il y a 4 ans

Tasigna and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study Advances in Chronic Myeloid Leukemia (CML) therapy led to an expected survival prolongation of > 20 years after diagnosis. So far, discontinuation of tyrosine kinase inhibitors led to recu...

Country Czech Republic, Germany, Switzerland
organs None
Specialty None

Opened trial

More information